# Comparative effectiveness of fingolimod versus interferons or glatiramer acetate for relapse rates in multiple sclerosis: a retrospective US claims database analysis

**Type:** Papers  
**Canonical URL:** https://scholariq.org/papers/comparative-effectiveness-of-fingolimod-versus-interferons-or-glatiramer-acetate/

## Facts

| Field | Value |
| --- | --- |
| Author Names | Niklas Bergvall,Charles Makin,Raquel Lahoz,Neetu Agashivala,Ashish Pradhan,Gorana Capkun,Allison Petrilla,Swapna Karkare,Catherine B. McGuiness,Jonathan R. Korn |
| Citations | 40 |
| DOI | 10.1185/03007995.2013.847411 |
| Fields | Biochemistry, Genetics and Molecular Biology,Medicine |
| Open Access | false |
| OA Status | closed |
| OpenAlex ID | https://openalex.org/W2138992948 |
| PMID | 24059944 |
| Type | article |
| Year | 2013 |

## Paper authors

- [Gorana Capkun](https://scholariq.org/researchers/gorana-capkun/)

## Paper journal

- [Current Medical Research and Opinion](https://scholariq.org/journals/current-medical-research-and-opinion/)

## Paper primary topic

- [Multiple Sclerosis Research Studies](https://scholariq.org/topics/multiple-sclerosis-research-studies/)

## Paper topics

- [Multiple Sclerosis Research Studies](https://scholariq.org/topics/multiple-sclerosis-research-studies/)
- [Sphingolipid Metabolism and Signaling](https://scholariq.org/topics/sphingolipid-metabolism-and-signaling/)
- [Peripheral Neuropathies and Disorders](https://scholariq.org/topics/peripheral-neuropathies-and-disorders/)

---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.